NCT06600607View on ClinicalTrials.gov

Pharmacodynamic Study of 300mg Pregabalin vs Placebo in Healthy Male Adults

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 7, 2024

Primary Completion Date

October 27, 2024

Study Completion Date

October 27, 2024

Conditions
Pain DetectionPain Threshold
Interventions
DRUG

pregabalin 300 mg

pregabalin is an FDA-approved anticonvulsant medication commonly used to treat nerve pain

OTHER

Placebo

biologically inactive placebo comparator

Trial Locations (1)

Unknown

New Zealand Clinical Research, Christchurch

Sponsors
All Listed Sponsors
lead

Latigo Biotherapeutics

INDUSTRY